JOSÉ ÁNGEL GARCÍA SÁENZ-rekin lankidetzan egindako argitalpenak (8)

2023

  1. Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors

    International Journal of Molecular Sciences, Vol. 24, Núm. 14

2021

  1. Genomic mapping of splicing-related genes identify amplifications in lsm1, clns1a, and ilf2 in luminal breast cancer

    Cancers, Vol. 13, Núm. 16

2020

  1. Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine

    Frontiers in Oncology, Vol. 10

2019

  1. A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors

    Frontiers in Immunology, Vol. 10

2011

  1. A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

    Breast Cancer Research and Treatment, Vol. 129, Núm. 3, pp. 939-946

2006

  1. Significance of the immunohistochemical detection of lymph node micrometastases in Stage II Colorectal Carcinoma

    Clinical and Translational Oncology, Vol. 8, Núm. 9, pp. 676-680

2004

  1. Phase II study of pegylated liposomal doxorubicin plus vinorelbine in breast cancer with previous anthracycline exposure

    Clinical Breast Cancer, Vol. 5, Núm. 5, pp. 353-357

2002

  1. Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: Results of a randomized study

    Revista Espanola de Quimioterapia, Vol. 15, Núm. 3, pp. 257-263